ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,195.17
0.69%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vyant Bio Inc (VYNT)

  7. Vyant Bio Inc (VYNT) Noticias

VYNT

Vyant Bio (VYNT)

Vyant Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VYNT
FechaHoraFuenteTítuloSímboloCompañía
26/12/202308:15GlobeNewswire Inc.Vyant Bio Provides Update on Winddown ActivitiesNASDAQ:VYNTVyant Bio Inc
01/11/202310:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Plan of DissolutionNASDAQ:VYNTVyant Bio Inc
24/10/202315:00GlobeNewswire Inc.Vyant Bio Announces Completion of StemoniX Asset SaleNASDAQ:VYNTVyant Bio Inc
19/10/202310:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
11/10/202310:45GlobeNewswire Inc.Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
28/09/202310:45GlobeNewswire Inc.Vyant Bio Announces Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
31/07/202316:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VYNTVyant Bio Inc
15/05/202307:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VYNTVyant Bio Inc
12/05/202307:00GlobeNewswire Inc.Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
10/05/202307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNTVyant Bio Inc
04/05/202315:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:VYNTVyant Bio Inc
04/05/202315:30GlobeNewswire Inc.Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
24/04/202315:50GlobeNewswire Inc.Vyant Bio Announces Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
28/03/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
24/03/202308:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202307:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VYNTVyant Bio Inc
03/02/202305:00GlobeNewswire Inc.Vyant Bio Commences a Cash Preservation Plan Including a Reduction in ForceNASDAQ:VYNTVyant Bio Inc
19/01/202315:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNTVyant Bio Inc
04/01/202315:15GlobeNewswire Inc.Vyant Bio Engages LifeSci Capital to Explore Strategic AlternativesNASDAQ:VYNTVyant Bio Inc
17/11/202205:20TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Cybin (CYBN)NASDAQ:VYNTVyant Bio Inc
16/11/202216:05GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for NeuroscienceNASDAQ:VYNTVyant Bio Inc
16/11/202215:43GlobeNewswire Inc.Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:VYNTVyant Bio Inc
15/11/202207:00GlobeNewswire Inc.Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business HighlightsNASDAQ:VYNTVyant Bio Inc
14/11/202215:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNTVyant Bio Inc
10/11/202216:13GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou FoundationNASDAQ:VYNTVyant Bio Inc
10/11/202207:00GlobeNewswire Inc.Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16NASDAQ:VYNTVyant Bio Inc
07/11/202208:00GlobeNewswire Inc.Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’NASDAQ:VYNTVyant Bio Inc
04/11/202205:10TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Kymera Therapeutics (KYMR)NASDAQ:VYNTVyant Bio Inc
03/11/202208:10GlobeNewswire Inc.Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. SubsidiaryNASDAQ:VYNTVyant Bio Inc
01/11/202207:00GlobeNewswire Inc.Vyant Bio Announces One-for-Five Reverse Stock SplitNASDAQ:VYNTVyant Bio Inc
 Showing the most relevant articles for your search:NASDAQ:VYNT

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados